Newsroom

Researchers find potential biomarker to detect ovarian cancer earlier


November 27, 2019

Dr. Ben Tsang and colleagues"Our research could lead to the development of a simple blood test to help detect ovarian cancer. This has the potential to save lives through early diagnosis.” -Dr. Benjamin Tsang, senior scientist at The Ottawa Hospital and professor at the University of Ottawa.The protein gelsolin may help doctors detect ovarian cancer earlier, according to a preliminary study led by Dr. Benjamin Tsang. Ovarian cancer is often diagnosed at a late stage because there is no reliable screening test to catch it early. 

The study published in Scientific Reports is the first to show that gelsolin in blood plasma is better at detecting early stage ovarian cancer than the commonly used cancer antigen 125. Plasma gelsolin was also better at predicting the amount of cancer cells left in the body after surgery, information that could help physicians and their patients choose the best treatment option. 

The study is based on plasma samples from 99 ovarian cancer patients. These findings will need to be confirmed in more patients before the test can be used clinically.

“Our research could lead to the development of a simple blood test to help detect ovarian cancer. This has the potential to save lives through early diagnosis.” -Dr. Benjamin Tsang, senior scientist at The Ottawa Hospital and professor at the University of Ottawa.

Authors: Meshach Asare-Werehene, Laudine Communal, Euridice Carmona, Tien Le, Diane Provencher, Anne-Marie Mes-Masson, Benjamin K. Tsang

Source: Scientific Reports

Funding: Canadian Institutes of Health Research. All research at The Ottawa Hospital is supported by The Ottawa Hospital Foundation.

The Ottawa Hospital: Inspired by research. Driven by compassion 

The Ottawa Hospital is one of Canada’s largest learning and research hospitals with over 1,100 beds, approximately 12,000 staff and an annual budget of over $1.2 billion. Our focus on research and learning helps us develop new and innovative ways to treat patients and improve care. As a multi-campus hospital, affiliated with the University of Ottawa, we deliver specialized care to the Eastern Ontario region, but our techniques and research discoveries are adopted around the world. We engage the community at all levels to support our vision for better patient care. See www.ohri.ca for more information about research at The Ottawa Hospital.

University of Ottawa: —A crossroads of cultures and ideas

The University of Ottawa is home to over 50,000 students, faculty and staff, who live, work and study in both French and English. Our campus is a crossroads of cultures and ideas, where bold minds come together to inspire game-changing ideas. We are one of Canada’s top 10 research universities—our professors and researchers explore new approaches to today’s challenges. One of a handful of Canadian universities ranked among the top 200 in the world, we attract exceptional thinkers and welcome diverse perspectives from across the globe. www.uottawa.ca

Media Contact

Amelia Buchanan
Senior Communication Specialist
Ottawa Hospital Research Institute
Office: 613-798-5555 x 73687
Cell: 613-297-8315
ambuchanan@ohri.ca

 

Disease and research area tags: Cancer, Ovarian cancer, Basic research

Scientific Program tags: Inflammation and Chronic Disease Program